CDH1 and benign prostatic hyperplasia: The progression of BPH is facilitated by EMT that leads to decreased E-cadherin expression and accumulation of mesenchymal-like cells derived from the prostatic epithelium and the endothelium10–12, mediated by TGF-β that acts via activation of Smad signaling12.